Novin Darou Pazhouh Iranian Co


Novin Daro Pajooh Iranian Company in Iran, Fars province, Shiraz city, was registered in 2014 under number 45809, this company is one of the most active pharmaceutical companies in the field of export, import and supply of pharmaceutical products, ie final products and pharmaceutical supplements, as well as Is medical equipment. The CEO of the company, Mr. Hossein Dehghani, expanded its activities in the domestic market by establishing a second branch in Iran and in the capital (Tehran).

Novin Daroo Pajooh Iranian Company is one of the reputable suppliers under the supervision of the Ministry of Health of Iran, which provides the need for special internal medicine drugs, which are usually listed and published on a monthly basis by the Food and Drug Administration as deficiency drugs.


The specialized medical categories in which our company works well are as follows:

  • oncology
  • Rheumatology
  • Internal
  • Ophthalmology
  • Heart disease
  • Biological products (such as immune globulins)
  • Cosmetic
  • Etc

We trade in the pharmaceutical market with various countries, such as the United States, Italy, Spain, Turkey and India.

It should be noted that the Italian supplement Health Plan is now monopolized and owned by our company and we are also developing our products, which now have two pharmaceutical supplement products called Luzentin and Optinovit available in the domestic market.

Novin Daroo Pajooh Iranian Company is proud to achieve its goals of achieving the production of more than twenty products of pharmaceutical products and pharmaceutical supplements according to the terms and conditions of the Food and Drug Administration of Iran in the next two years.

Novin Daroo Pajooh Iranian Company is always open to new opportunities and to extend its business fields with bonding new partnerships.

We are always remaining at your disposal for any kind of services and contact.

Contact Us
about pic

Our story

We believe that providing products with up-to-date innovations will be effective in accelerating treatment and increasing the quality of human life.